Skip to content

McKesson MCK Price / earnings

Price / earnings at other companies

Eli Lilly logo
Eli LillyLLY
32.5×-34.3×
Cardinal Health logo
Cardinal HealthCAH
32×+10.6×
Cencora logo
CencoraCOR
29.9×+6.0×
Viatris logo
ViatrisVTRS
6.5×-6.4×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
39.3×-4.6×
CVS Health logo
CVS HealthCVS
31.2×+15.0×

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.9%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$91.3B+25.7%
Enterprise value$89.6B+19.6%
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Calculated from McKesson’s reported figures.

Based on the most recent quarter.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's price / earnings?
McKesson (MCK) reported price / earnings of 22.3× in Q1 2026.
How has McKesson's price / earnings changed year-over-year?
McKesson's price / earnings decreased by 13.0% year-over-year, from 25.6× to 22.3×.
What is the long-term trend for McKesson's price / earnings?
Over 3 years (2023 to 2026), McKesson's price / earnings has grown at a 3.7% compound annual growth rate (CAGR), from 87.8× to 97.9×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.